A*02:01

A*02:01, also known as HLA-A*02:01, is a specific allele of the human leukocyte antigen (HLA) class I molecule, which plays a central role in the presentation of intracellular peptides to cytotoxic T lymphocytes. As a major histocompatibility complex (MHC) class I protein, it is highly significant in immunological research, particularly in studies involving antigen processing, immune recognition, and T-cell mediated responses. Its well-characterized peptide-binding specificity and prevalence in various populations make it a critical tool for investigating cellular immunity, antigen presentation mechanisms, and the development of immunotherapeutic strategies.

Immunology research: The HLA-A*02:01 molecule is widely utilized in immunological assays to study antigen presentation and T-cell activation. Researchers employ this allele to examine how endogenous or exogenous peptides are processed and presented on the cell surface, facilitating the identification of immunodominant epitopes. Such studies are foundational for understanding the mechanisms by which the immune system distinguishes self from non-self, as well as the molecular basis of immune surveillance in viral infections and tumor immunity.

Epitope mapping: The allele's defined peptide-binding motif allows for precise mapping of T-cell epitopes. Experimental systems expressing HLA-A*02:01 enable the screening and validation of peptide antigens derived from pathogens, tumors, or model systems. By elucidating which peptides are effectively presented, scientists can prioritize antigen candidates for subsequent functional studies or vaccine development, thereby accelerating the identification of immunologically relevant targets.

Vaccine development: HLA-A*02:01 is instrumental in preclinical evaluation of peptide-based vaccine candidates. Its widespread occurrence in human populations makes it a preferred model for assessing the immunogenicity of novel epitopes. Utilizing cell lines or recombinant systems expressing this allele, researchers can predict and validate the potential of specific peptides to be recognized by cytotoxic T lymphocytes, supporting rational vaccine design and optimization for broad population coverage.

T-cell receptor (TCR) studies: Functional assays involving HLA-A*02:01 are essential for dissecting TCR specificity and cross-reactivity. By presenting defined peptide-MHC complexes, investigators can analyze TCR binding affinities, signaling thresholds, and the molecular determinants of T-cell recognition. These insights are crucial for advancing adoptive T-cell therapies, engineering TCRs with enhanced specificity, and minimizing off-target effects in immunotherapeutic applications.

Cellular immunoassays and reagent development: The allele is frequently incorporated into cellular immunoassays, such as ELISPOT, flow cytometry, and cytotoxicity assays, to monitor antigen-specific T-cell responses. Additionally, recombinant forms of HLA-A*02:01 serve as valuable reagents for generating peptide-MHC tetramers, which are indispensable tools for isolating and characterizing antigen-specific T-cell populations. These applications support a broad range of basic and translational research endeavors focused on immune monitoring, biomarker discovery, and the evaluation of immunomodulatory interventions.

1. High fat diet and GLP-1 drugs induce pancreatic injury in mice

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

5. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics